For those with LVEF <40%, particularly withprior myocardial infarction or symptomatic heart failure, the following arerecommended [58, 59]: Beta-blockers, ACE inhibitors or angiotensin II receptorblockers (ARBs), though increasingly replaced by ARNIs. The gene discussed is ACE; the disease is heart failure.